文献速递外周动脉疾病

现代当代背景下慢性肢体威胁性缺血血管内介入治疗后无截肢生存的预测因素

Predictors of Amputation-free Survival after Endovascular Intervention for Chronic Limb-Threatening Ischemia in the Modern era.
PubMed 文献 · Ann Vasc Surg · 2022-05-17

本研究回顾性分析了2015至2019年间单家区域医院因慢性肢体威胁性缺血(CLTI)接受血管内血运重建的137条肢体(111例患者),评估无截肢生存(AFS)及其预测因素。中位随访16个月(IQR 4-29个月)后,非白人种族(HR=2.96 [1.42-6.17];P=0.004)和WIfI 4级伤口(HR=2.23 [1.10-4.52];P=0.026)是AFS降低的显著独立预测因素。成功血运重建后1年,仅59%±1%的患者存活且肢体完整。

要点

  • 非白人种族(HR=2.96 [1.42-6.17];P=0.004)和WIfI 4级伤口(HR=2.23 [1.10-4.52];P=0.026)是AFS降低的独立预测因素。
  • 成功血运重建后1年,仅59%±1%的患者存活且肢体完整。
  • 即使在意血管内时代,近半数CLTI患者首年内将失去肢体和/或生命。

核心结论

  • 尽管城市医疗服务和经皮外周介入技术不断进步,CLTI仍是高致残和高致死性疾病。
  • 即使在意血管内时代,近半数CLTI患者首年内将失去肢体和/或生命。
  • 晚期就诊仍很常见,血管内介入虽能可靠恢复通畅,但似不足以使多数患者恢复健康。

研究设计与样本

  • 回顾性研究,纳入2015至2019年间单家区域医院接受血管内血运重建的CLTI患者,共137条肢体(111例患者)。
  • 收集基线人口学特征、WIfI分期、技术细节和临床结局,主要终点为无截肢生存(AFS)。
  • 采用P值<0.05进行单变量筛选并纳入多变量模型。

主要发现

  • 合并症常见:糖尿病65%、充血性心力衰竭21%、透析依赖18%。
  • 多数血运重建肢体表现为晚期伤口:66%为WIfI 3-4期,47%为Rutherford 6类。
  • 不同种族间就诊时WIfI分期相似(P=0.26)。
  • 周围介入最常针对股腘动脉病变(69%),26%为多节段病变。
  • 经皮斑块旋切、支架植入和紫杉醇涂层或洗脱器械的使用率分别为68%、28%和15%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic limb-threatening (CLTI) is associated with 25% limb loss and 25% mortality at 1-year. Its lethality increases to 45% in patients subjected to a major amputation. Percutaneous peripheral intervention (PPI) constitutes an attractive and less morbid treatment option for patients with CLTI. The purpose of this study was to assess amputation-free survival (AFS) in a contemporary cohort treated with endovascular recanalization and assess its predictors. METHODS: Patients with CLTI undergoing endovascular revascularization at a single regional hospital between 2015-2019 were reviewed. Baseline demographic characteristics, Wound, Ischemia, and foot Infection (WIfI) stage, technical details, and clinical outcomes were tabulated. The primary endpoint was AFS; a P-value < 0.05 was used for univariate screening and inclusion in a multivariable model. RESULTS: A total of 137 limbs in 111 patients were studied. Comorbidities were prevalent and included diabetes (65%), congestive heart failure (21%), and dialysis dependence (18%). The majority of revascularized limbs presented with advanced wounds (66% WIfI stages 3-4; 47% Rutherford category 6). Presenting WIfI stages were similar across races (P = 0.26). Peripheral interventions most commonly targeted femoropopliteal disease (69%), although 26% were multilevel. Percutaneous atherectomy, stenting, and paclitaxel-coated or eluting devices were utilized in 68%, 28%, and 15% of cases, respectively. After a median follow-up of 16 months (interquartile range IQR = 4-29 months), significant independent predictors of reduced AFS included nonWhite race (HR = 2.96 [1.42-6.17]; P = 0.004) and WIfI stage 4 wounds (HR = 2.23 [1.10-4.52]; P = 0.026). At one year following successful revascularization, only 59% ± 1% of patients were alive with their limb intact. CONCLUSIONS: Despite considerable and consistent advances in urban health care delivery and the techniques of PPI, CLTI remains a morbid and deadly disease. Even in the endovascular era, nearly half of all patients presenting with CLTI will lose their limb and/or life within the first year. Unfortunately, late-stage presentation continues to be commonplace. Although endovascular intervention can reliably restore patency to affected arteries, this appears insufficient to restore most patients to health.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Joshi GS, Zhang SM, Wang K, et al. Predictors of Amputation-free Survival after Endovascular Intervention for Chronic Limb-Threatening Ischemia in the Modern era. Ann Vasc Surg. 2022. PMID: 35595207. doi:10.1016/j.avsg.2022.04.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。